ChiCTR1900024457: Phase I study for the safety of different B-cell target CART cells in the treatment of recurrent and refractory mature B-cell lymphoma involving maxillofacial and / or central nervous system involvement |
|
|
| Completed | N/A | 10 | | sequential B antigen chimeric antigen receptor T cells | Beijing Boren Hospital; Beijing Boren Hospital, Beijing Boren Hospital | recurrent and refractory mature B-cell lymphoma involving maxillofacial and / or central nervous system involvement | | | | |